Continuous infusions of arabinosyl cytosine in patients with neoplastic disease.
D001792:Blood Platelets / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003561:Cytarabine / Q000008:administration & dosage / Q000494:pharmacology*; D006413:Hematopoietic System / Q000187:drug effects*; D006454:Hemoglobins; D006801:Humans; D007958:Leukocyte Count; D009369:Neoplasms / Q000188:drug therapy*; D011086:Polycythemia / Q000139:chemically induced
D006454:Hemoglobins; D003561:Cytarabine